Danish researchers have offered more evidence that long-term inhaled corticosteriods given to control asthma in children do not have adverse effects on bone density.
Researchers at Kolding Hospital in Kolding, Denmark, studied 157 children with asthma who received an average daily dose of 504 µg of inhaled budesonide for at least 3 years. They included 111 control patients who had not used such a drug for more than 14 days. The researchers measured total body bone-mineral density, total body bone-mineral capacity, total bone calcium, and body composition. They found no differences between the 2 groups.
Voelker R. Corticosteroids and Bone Density. JAMA. 1998;279(10):739. doi:10.1001/jama.279.10.739-JWM80000-3-1
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.